These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21530824)

  • 21. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management].
    Ebner C
    Wien Med Wochenschr; 1999; 149(14-15):438-41. PubMed ID: 10584289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulators in the treatment of asthma.
    Long AA
    Allergy Asthma Proc; 2009; 30(2):109-19. PubMed ID: 19463201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Allergen-specific immunotherapy or desensitization].
    Demoly P; Michel FB
    Bull Acad Natl Med; 2009 May; 193(5):1127-44; discussion 1144-5. PubMed ID: 20120392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allergies: determinants of T2 lymphocyte polarization and desensitization mechanisms].
    Magnan A; Vervloet D
    Rev Mal Respir; 1997 Jun; 14(3):173-81. PubMed ID: 9411594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic immune modifiers: Trials and tribulations--are we there yet?
    Ballow M
    J Allergy Clin Immunol; 2006 Dec; 118(6):1209-15; quiz 1216-7. PubMed ID: 17157649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of allergic diseases with monoclonal anti-IgE antibody].
    Morita Y
    Nihon Rinsho; 2001 Oct; 59(10):2019-22. PubMed ID: 11676148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-IgE--a new treatment for allergic diseases].
    Berkun Y; Shalit M
    Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is interstitial cystitis an allergic disorder?: A case of interstitial cystitis treated successfully with anti-IgE.
    Lee J; Doggweiler-Wiygul R; Kim S; Hill BD; Yoo TJ
    Int J Urol; 2006 May; 13(5):631-4. PubMed ID: 16771742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy: The meta-analyses. What have we Learned?
    Calderón MA; Boyle RJ; Penagos M; Sheikh A
    Immunol Allergy Clin North Am; 2011 May; 31(2):159-73, vii. PubMed ID: 21530812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy. When indicated and how it works.
    Windom HH
    J Fla Med Assoc; 1996; 83(6):419-22. PubMed ID: 8752371
    [No Abstract]   [Full Text] [Related]  

  • 32. Bibliography. Current world literature. Immunotherapy.
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):534-7. PubMed ID: 15199922
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
    Massanari M; Nelson H; Casale T; Busse W; Kianifard F; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2010 Feb; 125(2):383-9. PubMed ID: 20159249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological basis of anti-IgE therapy.
    Chang TW
    Nat Biotechnol; 2000 Feb; 18(2):157-62. PubMed ID: 10657120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific immunotherapy of allergic diseases: application, effect and side-effects (author's transl)].
    Jarisch R; Sandor I; Götz M; Popow C
    Wien Klin Wochenschr Suppl; 1980; 117():15-8. PubMed ID: 6936976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen immunotherapy in asthma: current status and future perspectives.
    Nagata M; Nakagome K
    Allergol Int; 2010 Mar; 59(1):15-9. PubMed ID: 20093852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.